Regulation of osteoclast development by Notch signaling directed to osteoclast precursors and through stromal cells - PubMed (original) (raw)

. 2003 Mar 15;101(6):2227-34.

doi: 10.1182/blood-2002-06-1740. Epub 2002 Oct 31.

Affiliations

• PMID: 12411305
• DOI: 10.1182/blood-2002-06-1740

Free article

Regulation of osteoclast development by Notch signaling directed to osteoclast precursors and through stromal cells

Takayuki Yamada et al. Blood. 2003.

Free article

Abstract

Osteoclasts are derived from hematopoietic precursor cells belonging to the monocyte/macrophage lineage. Osteoclast development has been reported to be regulated by several molecules such as macrophage colony-stimulating factor (M-CSF), receptor activator of nuclear factor (NF)-kappaB ligand (RANKL), and a decoy receptor of RANKL, osteoprotegerin (OPG). Recently, it was demonstrated that the Notch signaling pathway regulates myeloid differentiation and antagonizes cell fate determination, however, the effect of Notch signaling on the osteoclast lineage has not been reported. In this study, we examined the effect of signaling via Notch receptors on the differentiation into osteoclasts by using cells from the bone marrow, spleen, and peritoneal cavity, and a cloned macrophagelike cell line. Osteoclastogenesis was inhibited by an immobilized Notch ligand, Delta-1. The dish-adherent bone marrow cells precultured with M-CSF expressed both Mac-1 and M-CSF receptors, c-Fms; osteoclastogenesis of these cells was efficiently inhibited. The immobilized Delta-1 also down-regulated the surface c-Fms expression, while the c-Fms gene expression was not changed. Genes for Notch receptors and Notch ligands are expressed in not only hematopoietic cells but also stromal cells that support osteoclast development. Constitutively active Notch1-transfected stromal cells showed increased expression of RANKL and OPG genes, and strong inhibition of M-CSF gene expression, resulting in reduction of their ability to support osteoclast development. Taken together, these findings indicate that Notch signaling affects both osteoclast precursors and stromal cells and thereby negatively regulates osteoclastogenesis.

PubMed Disclaimer

Similar articles

• Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
  Cao JJ, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP. Cao JJ, et al. J Bone Miner Res. 2005 Sep;20(9):1659-68. doi: 10.1359/JBMR.050503. Epub 2005 May 2. J Bone Miner Res. 2005. PMID: 16059637
• Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha.
  Hayashi S, Yamada T, Tsuneto M, Yamane T, Takahashi M, Shultz LD, Yamazaki H. Hayashi S, et al. J Immunol. 2003 Nov 15;171(10):5130-9. doi: 10.4049/jimmunol.171.10.5130. J Immunol. 2003. PMID: 14607912
• Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
  Itoh K, Udagawa N, Matsuzaki K, Takami M, Amano H, Shinki T, Ueno Y, Takahashi N, Suda T. Itoh K, et al. J Bone Miner Res. 2000 Sep;15(9):1766-75. doi: 10.1359/jbmr.2000.15.9.1766. J Bone Miner Res. 2000. PMID: 10976996
• A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.
  Takahashi N, Udagawa N, Suda T. Takahashi N, et al. Biochem Biophys Res Commun. 1999 Mar 24;256(3):449-55. doi: 10.1006/bbrc.1999.0252. Biochem Biophys Res Commun. 1999. PMID: 10080918 Review.
• The molecular basis of osteoclast differentiation and activation.
  Suda T, Kobayashi K, Jimi E, Udagawa N, Takahashi N. Suda T, et al. Novartis Found Symp. 2001;232:235-47; discussion 247-50. doi: 10.1002/0470846658.ch16. Novartis Found Symp. 2001. PMID: 11277084 Review.

Cited by

• Periplogenin attenuates LPS-mediated inflammatory osteolysis through the suppression of osteoclastogenesis via reducing the NF-κB and MAPK signaling pathways.
  Gan K, Lian H, Yang T, Huang J, Chen J, Su Y, Zhao J, Xu J, Liu Q. Gan K, et al. Cell Death Discov. 2024 Feb 17;10(1):86. doi: 10.1038/s41420-024-01856-0. Cell Death Discov. 2024. PMID: 38368392 Free PMC article.
• The Notch1 signaling pathway directly modulates the human RANKL-induced osteoclastogenesis.
  Padovano C, Bianco SD, Sansico F, De Santis E, Tamiro F, Colucci M, Totti B, Di Iasio S, Bruno G, Panelli P, Miscio G, Mazza T, Giambra V. Padovano C, et al. Sci Rep. 2023 Dec 1;13(1):21199. doi: 10.1038/s41598-023-48615-2. Sci Rep. 2023. PMID: 38040752 Free PMC article.
• Babam2 negatively regulates osteoclastogenesis by interacting with Hey1 to inhibit Nfatc1 transcription.
  Jin F, Zhu Y, Liu M, Wang R, Cui Y, Wu Y, Liu G, Wang Y, Wang X, Ren Z. Jin F, et al. Int J Biol Sci. 2022 Jul 11;18(11):4482-4496. doi: 10.7150/ijbs.72487. eCollection 2022. Int J Biol Sci. 2022. PMID: 35864959 Free PMC article.
• Regulation of TNF-Induced Osteoclast Differentiation.
  Yao Z, Getting SJ, Locke IC. Yao Z, et al. Cells. 2021 Dec 31;11(1):132. doi: 10.3390/cells11010132. Cells. 2021. PMID: 35011694 Free PMC article. Review.
• The multifunctional role of Notch signaling in multiple myeloma.
  Sabol HM, Delgado-Calle J. Sabol HM, et al. J Cancer Metastasis Treat. 2021;7:20. doi: 10.20517/2394-4722.2021.35. Epub 2021 Apr 14. J Cancer Metastasis Treat. 2021. PMID: 34778567 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal